ArticleVaccines2024

Evaluation of Safety, Immunogenicity and Cross-Reactive Immunity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, in Older Adults.

Bart Jacobs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.